1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003. 289:3095–3105.
2. Prado Jde A, Kerr-Corrêa F, Lima MC, da Silva GG, Santos JL. Relations between depression, alcohol and gender in the metropolitan region of São Paulo, Brazil. Cien Saude Colet. 2012. 17:2425–2434.
Article
3. Bromberger JT, Kravitz HM. Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years. Obstet Gynecol Clin North Am. 2011. 38:609–625.
Article
4. Exebio JC, Zarini GG, Exebio C, Huffman FG. Healthy Eating Index scores associated with symptoms of depression in Cuban-Americans with and without type 2 diabetes: a cross sectional study. Nutr J. 2011. 10:135.
Article
5. Saeed SA, Bloch RM, Antonacci DJ. Herbal and dietary supplements for treatment of anxiety disorders. Am Fam Physician. 2007. 76:549–556.
6. Weeks BS. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian. Med Sci Monit. 2009. 15:RA256–RA262.
7. Bertone-Johnson ER, Powers SI, Spangler L, Brunner RL, Michael YL, Larson JC, Millen AE, Bueche MN, Salmoirago-Blotcher E, Liu S, Wassertheil-Smoller S, Ockene JK, Ockene I, Manson JE. Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women. Am J Clin Nutr. 2011. 94:1104–1112.
Article
8. Pasco JA, Jacka FN, Williams LJ, Evans-Cleverdon M, Brennan SL, Kotowicz MA, Nicholson GC, Ball MJ, Berk M. Dietary selenium and major depression: a nested case-control study. Complement Ther Med. 2012. 20:119–123.
Article
9. De Souza MC, Walker AF, Robinson PA, Bolland K. A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study. J Womens Health Gend Based Med. 2000. 9:131–139.
Article
10. Carroll D, Ring C, Suter M, Willemsen G. The effects of an oral multivitamin combination with calcium, magnesium, and zinc on psychological well-being in healthy young male volunteers: a double-blind placebo-controlled trial. Psychopharmacology (Berl). 2000. 150:220–225.
Article
11. Konopka LM, Cooper R, Crayton JW. Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients. Biol Psychiatry. 1996. 39:708–713.
Article
12. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem. 2005. 280:17294–17300.
Article
13. Doherty TM, Asotra K, Fitzpatrick LA, Qiao JH, Wilkin DJ, Detrano RC, Dunstan CR, Shah PK, Rajavashisth TB. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A. 2003. 100:11201–11206.
Article
14. Foster TC, Kumar A. Calcium dysregulation in the aging brain. Neuroscientist. 2002. 8:297–301.
Article
15. Plein H, Berk M, Eppel S, Butkow N. Augmented platelet calcium uptake in response to serotonin stimulation in patients with major depression measured using Mn2+ influx and 45Ca2+ uptake. Life Sci. 2000. 66:425–431.
Article
16. Mockett BG, Guévremont D, Wutte M, Hulme SR, Williams JM, Abraham WC. Calcium/calmodulin-dependent protein kinase II mediates group I metabotropic glutamate receptor-dependent protein synthesis and long-term depression in rat hippocampus. J Neurosci. 2011. 31:7380–7391.
Article
17. Jimerson DC, Post RM, Carman JS, van Kammen DP, Wood JH, Goodwin FK, Bunney WE Jr. CSF calcium: clinical correlates in affective illness and schizophrenia. Biol Psychiatry. 1979. 14:37–51.
18. Bae HS, Kim SY, Ahnv HS, Cho YK. Comparison of nutrient intake, life style variables, and pregnancy outcomes by the depression degree of pregnant women. Nutr Res Pract. 2010. 4:323–331.
Article
19. Ghanbari Z, Haghollahi F, Shariat M, Foroshani AR, Ashrafi M. Effects of calcium supplement therapy in women with premenstrual syndrome. Taiwan J Obstet Gynecol. 2009. 48:124–129.
Article
20. Durlach J, Pagès N, Bac P, Bara M, Guiet-Bara A. Importance of magnesium depletion with hypofunction of the biological clock in the pathophysiology of headhaches with photophobia, sudden infant death and some clinical forms of multiple sclerosis. Magnes Res. 2004. 17:314–326.
21. Abraham GE. Nutritional factors in the etiology of the premenstrual tension syndromes. J Reprod Med. 1983. 28:446–464.
22. German-Fattal M, Lecerf F, Sabbagh F, Maurois P, Durlach J, Bac P. Neuroprotective gene profile in the brain of magnesium-deficient mice. Biomed Pharmacother. 2008. 62:264–272.
Article
23. Jung KI, Ock SM, Chung JH, Song CH. Associations of serum Ca and Mg levels with mental health in adult women without psychiatric disorders. Biol Trace Elem Res. 2010. 133:153–161.
Article
24. Jacka FN, Maes M, Pasco JA, Williams LJ, Berk M. Nutrient intakes and the common mental disorders in women. J Affect Disord. 2012. 141:79–85.
Article
25. Derom ML, Martínez-González MA, Sayón-Orea Mdel C, Bes-Rastrollo M, Beunza JJ, Sánchez-Villegas A. Magnesium intake is not related to depression risk in Spanish university graduates. J Nutr. 2012. 142:1053–1059.
Article
26. Rural Resources Development Institute. Food Composition Tables. 2006. 7th edition. Seoul: Hyoil books.
27. Zung WW. A Self-rating depression scale. Arch Gen Psychiatry. 1965. 12:63–70.
Article
28. Knight RG, Waal-Manning HJ, Spears GF. Some norms and reliability data for the State--Trait Anxiety Inventory and the Zung Self-Rating Depression scale. Br J Clin Psychol. 1983. 22:245–249.
Article
29. Maes M, De Ruyter M, Claes R, Suy E. Self rated depression in relation to DSM-III classification: a statistical isolinear multiple components analysis. Acta Psychiatr Scand. 1988. 77:27–31.
Article
30. Carman JS, Wyatt RJ. Calcium: bivalent cation in the bivalent psychoses. Biol Psychiatry. 1979. 14:295–336.
31. Penland JG, Johnson PE. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol. 1993. 168:1417–1423.
Article
32. Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet. 2009. 105:158–161.
Article
33. Bertone-Johnson ER, Hankinson SE, Bendich A, Johnson SR, Willett WC, Manson JE. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med. 2005. 165:1246–1252.
Article
34. Ministry of Health and Welfare. Korea Centers for Disease Control and Prevention. 2009 National Health Statistics: The 4th Korea National Health and Nutrition Examination Survey, the third year. 2010. Cheongwon: Korea Centers for Disease Control and Prevention;239.
35. Roman SA, Sosa JA, Pietrzak RH, Snyder PJ, Thomas DC, Udelsman R, Mayes L. The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism. Ann Surg. 2011. 253:131–137.
Article
36. Tietz NW. Fundamentals of Clinical Chemistry. 1987. 3rd edition. Philadelphia: W.B. Saunders.
37. Schuette SA, Linkswiler HM. Calcium. Present Knowledge in Nutrition. 1984. 15th edition. Washington D.C.: The Nutrition Foundation Inc.;400–412.
38. Fromm L, Heath DL, Vink R, Nimmo AJ. Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. J Am Coll Nutr. 2004. 23:529S–533S.
Article
39. Aikawa JK. Magnesium: Its Biological Significance. 1981. Florida: CRC Press Inc..